|
|
|
|
|
|
|
Reshape Lifesciences Inc (RSLS)
|
|
0.53 -0.001 (-0.19%)
|
04-26 16:00
|
|
Open:
|
0.53
|
Pre. Close:
|
0.531
|
|
High:
|
0.542
|
Low:
|
0.53
|
|
Volume:
|
99,325
|
Market Cap:
|
17M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
0.541 - 0.545
|
0.545 - 0.548
|
|
Low:
|
0.521 - 0.526
|
0.526 - 0.53
|
|
Close:
|
0.523 - 0.53
|
0.53 - 0.537
|
|
|
|
Technical analysis (as of: 2018-04-26 4:33:34 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 1.29 One year: 1.88
|
|
Support:
|
Support1: 0.28 Support2: 0.23
|
|
Resistance:
|
Resistance1:
1.10 Resistance2: 1.61
|
|
Pivot:
|
0.63 
|
|
Moving Averages:
|
MA(5): 0.58 MA(20): 0.68
MA(100): 1.32 MA(250): 2.44
|
|
MACD:
|
MACD(12,26):
-0.18  Signal(12,26,9): -0.19
|
|
%K %D:
|
%K(14,3): 45.43 %D(3): 36.36
|
|
RSI:
|
RSI(14): 19.19
|
|
52-Week:
|
High: 6.45
Low: 0.28 Change(%): -87.4
|
|
Average Vol(K):
|
3-Month: 22473
10-Days 18397
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.RSLS has closed below the lower band by 5.1%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for RSLS is to continue within current trading range. It is unclear right now based on current numbers. 58.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to RSLS's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-04-24T08:00:00-04:00
ReShape Lifesciences Continues to Grow Presence in Middle East with Distribution in Bahrain
2018-04-18T08:30:00-04:00
Forty Surgeons Trained on ReShape Balloon at Hands-On Course During SAGES 2018
2018-04-10T08:30:00-04:00
ReShape Lifesciences Pioneers New Bio-electronic Technology for Treatment of Type 2 Diabetes
2018-04-03T11:48:30-04:00
Your Daily Pharma Scoop: MediciNova Makes A Strong Comeback, Alkermes' Setback, BioLife Preliminary Q1 Results
2018-04-03T08:30:00-04:00
ReShape Lifesciences Continues Expansion in Middle East with Approval of ReShape Balloon in Saudi Arabia
2018-04-02T22:59:02-04:00
ReShape Lifesciences' (RSLS) CEO Dan Gladney on Q4 2017 Results - Earnings Call Transcript
2018-04-02T16:24:06-04:00
ReShape Lifesciences misses by $0.30, misses on revenue
2018-04-02T16:01:00-04:00
ReShape Lifesciences Announces Fourth Quarter and Year End 2017 Financial Results
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
